Evonik and Perstorp sign joint research agreement

Evonik and Perstorp have signed a research agreement for the development of new animal nutrition products and are furthermore investigating future options for commercial partnerships.

Evonik and Perstorp have signed a research agreement for the development of new animal nutrition products and are furthermore investigating future options for commercial partnerships.

This joint approach combines Evonik’s access to the unique gut health simulation system and probiotics portfolio with Perstorp’s innovative ester technology platform for efficient and safe acid application. In that way combining advanced science and practical experience from both well-established companies will deliver breakthrough innovation supporting the requirements for tomorrow’s animal farming. Specifically, the products to be developed will be aimed at improving the gut health of the animals and at the same time keep the performance compared to antibiotic growth promoters.

Roger Mann, Executive Vice President Animal Nutrition, Perstorp, said: “As a leading specialty chemicals innovator, we help prevent antibiotic resistance from becoming an even bigger problem by offering alternative, more sustainable solutions for sound and profitable animal production. “We’re excited by the opportunity this partnership with Evonik brings to build on the expertise of both companies to tackle this global challenge.”

Dr. Christoph Kobler, Head of Product Line Sustainable Healthy Nutrition at Evonik, added: “Both companies believe that the challenges of antimicrobial resistance in animal production can only be tackled with a holistic approach, using new and innovative solutions instead of the preventive use of antibiotics. This approach will help to ensure that sustainable livestock production remains possible without resorting to that intervention.”

Page 1 of 51
Next Page